Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Small Methods|February 17, 2022
Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery ApplicationsAsako Shimoda, Risako Miura, Hiroaki Tateno, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2024
Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4<sub>p230-239</sub>/HLA-A∗02:01 complexLinan Wang, Masahiro Matsumoto, Yasushi Akahori, et al.
The American Journal of Surgical Pathology|August 26, 2006
Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assayHiroaki Yagi, Naohiro Seo, Akihiro Ohshima, et al.
Biomedicines|August 23, 2020
Skin Inflammation and Testicular Function: Dermatitis Causes Male Infertility via Skin-Derived CytokinesAi Umaoka, Hiroki Takeuchi, Kento Mizutani, et al.
Oncoimmunology|October 21, 2016
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndromeLinan Wang, Ning Ma, Sachiko Okamoto, et al.
Journal of Extracellular Vesicles|March 15, 2022
Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion-exchange methodNaohiro Seo, Junko Nakamura, Tsuguhiro Kaneda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Introducing arginine residues into scFv in CAR-T cells shows promising antitumor effectsShingo Maeta, Atsushi Fukunaga, Yuriko Egashira, et al.
Cancer Research|October 19, 2006
Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunizationHiroaki Yagi, Hideo Hashizume, Takahiro Horibe, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cellsMasato Kato, Yutaro Nakamura, Takafumi Suda, et al.
Cancer Science|September 7, 2023
T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host diseaseSatomi Okada, Daisuke Muraoka, Kiyoshi Yasui, et al.
Pageof 4